What is the Return on Assets (ROA) of Ibio this year?
The Return on Assets (ROA) of Ibio is -1.58 undefined this year.
Ibio ROA 2024
Ibio ROA
-1.58
Ticker
IBIO
ISIN
US4510332038
WKN
A2JNBU
In 2024, Ibio's return on assets (ROA) was -1.58, a 211.26% increase from the -0.51 ROA in the previous year.
Ibio Aktienanalyse
What does Ibio do?
Ibio Inc is a US biopharmaceutical company founded in 2008. It is headquartered in Bryan, Texas and employs approximately 130 employees. The company is listed on the New York Stock Exchange (NYSE: IBIO). The business model of Ibio Inc is to develop innovative biopharmaceutical products and sell them in the market. The company utilizes plant expression systems technology to extract proteins and antibodies from plant cells, which significantly reduces production costs, allowing for cost-efficient manufacturing of rare and expensive medications. The company is divided into various divisions, including research and development, manufacturing of biopharmaceuticals, and vaccine production. In the research and development field, Ibio Inc focuses on innovative products in oncology and infectious diseases. One example of their products is IBIO-100, which is intended for the treatment of breast and prostate cancer. Another product of Ibio Inc is IBIO-CFB03, a vaccine against COVID-19 produced using plant expression technology. In 2020, the company formed a partnership with the Brazilian biotech company CC-Pharming Ltda. for this vaccine. Additionally, Ibio Inc is involved in the production of biopharmaceuticals, including various antibodies used in the treatment of cancer. One example is IBIO-101, a monoclonal antibody against the tumor protein folate receptor alpha, which can be used in the therapy of ovarian, breast, and lung cancer. The company collaborates closely with various partners in the pharmaceutical industry to bring its products to the market. This includes working with CC-Pharming, with whom they developed the COVID-19 vaccine, as well as Chinese biotech company CC-Pharming Shanghai Co. Ltd., which serves as a production partner for Ibio Inc. Ibio Inc is an innovative company that enables cost-efficient production of biopharmaceuticals through the use of plant expression technology. The company primarily focuses on oncology and infectious diseases and collaborates with partners in the pharmaceutical industry to bring its products to the market. Ibio ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Ibio's Return on Assets (ROA)
Ibio's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Ibio's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Ibio's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Ibio’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Ibio stock
What was the ROA of Ibio compared to the previous year?
The ROA of Ibio has increased by 211.26% compared to the previous year.
What consequences do high ROA have for investors of Ibio?
A high ROA is advantageous for investors of Ibio, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Ibio?
A low ROA can be unfavorable for investors of Ibio as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Ibio affect the company?
An increase in ROA of Ibio can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Ibio impact the company?
A reduction in the ROA of Ibio can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Ibio?
Some factors that can influence the ROA of Ibio include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Ibio important for investors?
The ROA of Ibio is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Ibio take to improve ROA?
To improve ROA, Ibio can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Ibio pay?
Over the past 12 months, Ibio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ibio is expected to pay a dividend of 0 USD.
What is the dividend yield of Ibio?
The current dividend yield of Ibio is .
When does Ibio pay dividends?
Ibio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Ibio?
Ibio paid dividends every year for the past 0 years.
What is the dividend of Ibio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Ibio located?
Ibio is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ibio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ibio from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.
When did Ibio pay the last dividend?
The last dividend was paid out on 9/19/2024.
What was the dividend of Ibio in the year 2023?
In the year 2023, Ibio distributed 0 USD as dividends.
In which currency does Ibio pay out the dividend?
The dividends of Ibio are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Ibio
Our stock analysis for Ibio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ibio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
